Who owns ALNYLAM PHARMACEUTICALS, INC. (ALNY)? Elite investor 13F holders

6 tracked elite investors reported holding ALNYLAM PHARMACEUTICALS, INC as of 2026-09-30, including Dodge & Cox Funds, D.E. Shaw, Gotham Asset Management, Bridgewater Associates, Maverick Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

6 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and hATTR amyloidosis; Leqvio for hypercholesterolemia; Qfitlia for hemophilia A or B; GIVLAARI for acute…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Dodge & Cox FundsALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-13 00:00:00495081836.00 USD2006492.000000SharesaddOriginal filing
D.E. ShawALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:00267103205.00 USD1082529.000000SharesreduceOriginal filing
Gotham Asset ManagementALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:0036792388.00 USD149114.000000SharesaddOriginal filing
Bridgewater AssociatesALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:007022961.00 USD28463.000000SharesreduceOriginal filing
Maverick CapitalALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:00223793.00 USD907.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsALNYLAM PHARMACEUTICALS INCSHARE2026-09-302026-11-17 00:00:002714.00 USD11.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown